Emmaus Life Sciences, Inc. (EMMA) Reports Q2 Loss of $0.02

Emmaus Life Sciences, Inc. (OTC: EMMA) reported Q2 EPS of ($0.02). Revenue for the quarter came in at $2.82 million.

For earnings history and earnings-related data on Emmaus Life Sciences, Inc. (EMMA) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Nomura/Instinet Downgrades Korea Electric Power Corp. (015760:KS) (KEP) to Neutral
• JPMorgan Downgrades ASX Limited (ASX:AU) (ASXFY) to Neutral